MICROVASCULAR DAMAGE IN THROMBOTIC THROMBOCYTOPENIC PURPURA (MITHO)
STUDY OF MICROVASCULAR DAMAGE IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
The goal of this interventional, non-pharmacological clinical study is to assess microcirculatory dysfunction in patients with thrombotic thrombocytopenic purpura (TTP), both during the acute phase and in remission, compared with the general population.
Microcirculatory damage will be defined as the presence of at least one abnormal instrumental finding among brain magnetic resonance imaging (MRI), optical coherence tomography angiography (OCT-A), and nailfold videocapillaroscopy.
This is a monocentric, national study including two patient cohorts:
Cohort 1: patients enrolled during the acute phase Cohort 2: patients enrolled during remission Participants will be followed for three years with a total of five study visits.
Researchers will not test any drug but will perform detailed clinical, laboratory, and instrumental assessments to evaluate microvascular involvement over time.
Participants will:
- Undergo clinical evaluation, including internal medicine and neurological assessments
- Provide blood and urine samples for laboratory analyses
- Undergo instrumental examinations such as brain MRI, OCT-A, and nailfold videocapillaroscopy
- Receive psychological/neuropsychological evaluations
- Attend follow-up visits over a 3-year period (at baseline, 3 months [cohort 1 only], 12, 24, and 36 months)
Studie Overzicht
Toestand
Toestand
Conditie
Conditie
Interventie / Behandeling
Interventie / Behandeling
- Diagnostische toets: Factor VIII (FVIII)
- Diagnostische toets: Von Willebrand factor (VWF) antigen
- Diagnostische toets: VWF:RCo
- Diagnostische toets: VWF-propeptide
- Diagnostische toets: VWF multimers
- Diagnostische toets: sP-selectin
- Diagnostische toets: sCD40L
- Diagnostische toets: F1+2
- Diagnostische toets: VEGF-A
- Diagnostische toets: VCAM
- Diagnostische toets: ICAM
- Diagnostische toets: IL-1β
- Diagnostische toets: IL-6
- Diagnostische toets: PTX3
- Diagnostische toets: BlyS
- Diagnostische toets: Neutrophil elastase and myeloperoxidase (NETs) markers
- Diagnostische toets: soluble C5b-9
- Diagnostische toets: C5a
- Diagnostische toets: NFL
- Diagnostische toets: GFAP
- Genetisch: Whole exome sequencing - WES
- Diagnostische toets: Proteomic Analysis
- Diagnostische toets: evaluation of thrombus formation with Total Thrombus formation Analysis System (T-TAS)
- Diagnostische toets: Microfluidic Flow Chamber
Studietype
Studietype
Inschrijving (Geschat)
Inschrijving
Fase
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Milano
-
Milan, Milano, Italië, 20122
- Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico
-
-
Deelname Criteria
Geschiktheidscriteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- aged ≥18 years
- diagnosis of TTP (either congenital or acquired immune-mediated TTP)
- referred at our hospital (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, S.C. Medicina - Emostasi e Trombosi)
- providing a signed informed consent
Exclusion Criteria:
- Patients who do not possess the above inclusion criteria
- Patients who have known contraindications to the instrumental exam included in the study.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Diagnostisch
- Toewijzing: Niet-gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Aantal wapens
Wapens en interventies
Deelnemersgroep / ArmDeelnemersgroep / Arm |
Interventie / BehandelingInterventie / Behandeling |
|---|---|
|
Ander: Acute TTP
Patients enrolled during acute phase (cohort 1), T0= within 15 days from hospital admission.
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
|
Ander: Remission TTP
Patients enrolled during clinical remission (cohort 2), T0= check-up visit performed at more than 3 months from clinical response of the previous episode
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Prevalence
Tijdsspanne: From enrollment to the last visit (after 36 months from Time 0)
|
Prevalence of microcirculation damage in iTTP patients compared to general population
|
From enrollment to the last visit (after 36 months from Time 0)
|
Secundaire uitkomstmaten
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Cerebral microcirculation lesions
Tijdsspanne: From enrollment to the last visit (after 36 months from Time 0)
|
Evaluate cerebral microcirculation lesions (via brain MRI) in both acute and remission phases of TTP to monitor organ damage progression over time
|
From enrollment to the last visit (after 36 months from Time 0)
|
|
Retinal microcirculation changes
Tijdsspanne: From enrollment to the last visit (after 36 months from Time 0)
|
Assess retinal microcirculation changes (using OCT and OCT-A) during acute and remission phases of TTP to track organ damage evolution
|
From enrollment to the last visit (after 36 months from Time 0)
|
|
Peripheral microcirculation
Tijdsspanne: From enrollment to the last visit (after 36 months from Time 0)
|
Analyze peripheral microcirculation (with nailfold videocapillaroscopy) in acute and remission phases to evaluate progression of organ involvement in TTP
|
From enrollment to the last visit (after 36 months from Time 0)
|
|
Association between cerebral MRI lesions and cognitive or psychological symptoms
Tijdsspanne: From enrollment to the last visit (36 months from Time 0)
|
Explore the relationship between cerebral MRI lesions and cognitive or psychological symptoms during TTP remission, assessing symptom progression
|
From enrollment to the last visit (36 months from Time 0)
|
|
Modification of preclinical biomarkers
Tijdsspanne: From enrollment to the last visit (36 months from Time 0)
|
Explore the modification of preclinical biomarkers over time at different stage of the disease
|
From enrollment to the last visit (36 months from Time 0)
|
|
Associations between preclinical biomarkers and microcirculatory damage
Tijdsspanne: From enrollment to the last visit (36 months from Time 0)
|
Identify associations between preclinical biomarkers and microcirculatory damage in both acute and remission phases of TTP to predict risk and progression
|
From enrollment to the last visit (36 months from Time 0)
|
Medewerkers en onderzoekers
Sponsor
Sponsor
Medewerkers
Medewerkers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Studie start
Primaire voltooiing (Geschat)
Primaire voltooiing
Studie voltooiing (Geschat)
Studie voltooiing
Studieregistratiedata
Eerst ingediend
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Eerst geplaatst
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update geplaatst
Laatste update ingediend die voldeed aan QC-criteria
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Cytopenie
- Pathologische processen
- Bloeding
- Manifestaties van de huid
- Hematologische ziekten
- Bloedstollingsstoornissen
- Bloedplaatjesstoornissen
- Trombotische microangiopathieën
- Purpura, trombocytopenisch
- Purpura
- Trombocytopenie
- Trombofilie
- Pathologische aandoeningen, tekenen en symptomen
- Tekenen en symptomen
- Hemische en lymfatische ziekten
- Purpura, trombotische trombocytopenie
- Onderzoekstechnieken
- Genetische technieken
- Sequentie -analyse
- Sequentie -analyse, DNA
- Hele genoomsequencing
- Exome -sequencing
Andere studie-ID-nummers
Andere studie-ID-nummers
- IRCCSMaggioreH (IRCCSMaggioreH)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .